[
  {
    "ts": null,
    "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=69ec55acdb09fa12c273aba5402b112a9ad0e848814984d7a662f1d09ce57851",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751474820,
      "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
      "id": 135819320,
      "image": "",
      "related": "COR",
      "source": "MarketWatch",
      "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=69ec55acdb09fa12c273aba5402b112a9ad0e848814984d7a662f1d09ce57851"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add HealthEquity Stock to Your Portfolio Now",
    "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=d8e2a5f8ca0d8004db17e4204a59ef7a2de528efbb3ea7c2ff2ded8bb80c0756",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751464980,
      "headline": "Here's Why You Should Add HealthEquity Stock to Your Portfolio Now",
      "id": 135713199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "HQY's sustained strength in HSAs raises optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=d8e2a5f8ca0d8004db17e4204a59ef7a2de528efbb3ea7c2ff2ded8bb80c0756"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion",
    "summary": "ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.",
    "url": "https://finnhub.io/api/news?id=81ae155aa40db5e40f2f69234b452355d2cfbb3734e1c941c749756ab62910a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751464860,
      "headline": "Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion",
      "id": 135714146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.",
      "url": "https://finnhub.io/api/news?id=81ae155aa40db5e40f2f69234b452355d2cfbb3734e1c941c749756ab62910a1"
    }
  },
  {
    "ts": null,
    "headline": "Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?",
    "summary": "DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.",
    "url": "https://finnhub.io/api/news?id=92759681eca709c87fe21026aff58c4ac614428cfdb3ad9995317bba20e18556",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751460420,
      "headline": "Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?",
      "id": 135712997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.",
      "url": "https://finnhub.io/api/news?id=92759681eca709c87fe21026aff58c4ac614428cfdb3ad9995317bba20e18556"
    }
  },
  {
    "ts": null,
    "headline": "COO Stock Declines Despite Strong Core Growth Amid Fertility Woes",
    "summary": "The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.",
    "url": "https://finnhub.io/api/news?id=827120970fe93e59ce09f215abf2412088ff1c5919386483877c717113bdea62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751458860,
      "headline": "COO Stock Declines Despite Strong Core Growth Amid Fertility Woes",
      "id": 135711637,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.",
      "url": "https://finnhub.io/api/news?id=827120970fe93e59ce09f215abf2412088ff1c5919386483877c717113bdea62"
    }
  },
  {
    "ts": null,
    "headline": "Is it Apt to Retain Alcon Stock in Your Portfolio for Now?",
    "summary": "ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.",
    "url": "https://finnhub.io/api/news?id=568c925dcd0cb38c0874ebdf99033fb76d90cc9dc7ec5df2258449897e75ed38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751458620,
      "headline": "Is it Apt to Retain Alcon Stock in Your Portfolio for Now?",
      "id": 135711733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.",
      "url": "https://finnhub.io/api/news?id=568c925dcd0cb38c0874ebdf99033fb76d90cc9dc7ec5df2258449897e75ed38"
    }
  },
  {
    "ts": null,
    "headline": "3 Big Reasons to Love Cencora (COR)",
    "summary": "Since July 2020, the S&P 500 has delivered a total return of 97.8%. But one standout stock has doubled the market - over the past five years, Cencora has surged 196% to $296 per share. Its momentum hasn’t stopped as it’s also gained 31.7% in the last six months, beating the S&P by 26.1%.",
    "url": "https://finnhub.io/api/news?id=a8e44b95ca8b8cc48532ca975f1de5a1024438e47d4dfdd30a6faebda8ef01b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751429246,
      "headline": "3 Big Reasons to Love Cencora (COR)",
      "id": 135711391,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Since July 2020, the S&P 500 has delivered a total return of 97.8%. But one standout stock has doubled the market - over the past five years, Cencora has surged 196% to $296 per share. Its momentum hasn’t stopped as it’s also gained 31.7% in the last six months, beating the S&P by 26.1%.",
      "url": "https://finnhub.io/api/news?id=a8e44b95ca8b8cc48532ca975f1de5a1024438e47d4dfdd30a6faebda8ef01b7"
    }
  }
]